India's Brightest Healthcare Innovators Take Centre Stage at IIT Delhi
India’s FITT IIT Delhi, in partnership with Pfizer India and Social Alpha, hosted an event showcasing 20 winning startups from the Pfizer INDovation Program 2025-26, which provides IP and commercialization support to accelerate healthcare innovation. Leaders including Dr. M. Srinivas and Shri Bhuvnesh Pratap Singh emphasized the role of digital health infrastructure and industry-academia collaboration in shaping India’s future as a global healthcare innovator by 2047.
The Indian Institute of Technology Delhi’s FITT, in collaboration with Pfizer India and Social Alpha, hosted *Translating What’s Next: Securing the Future of Innovation* on June 5 in New Delhi. The event highlighted 20 winning startups from the Pfizer INDovation Program (IP Support Edition) 2025-26, a first-of-its-kind initiative offering technical, legal, and commercial support to foster India’s healthcare innovation ecosystem. The program aims to bridge gaps in intellectual property protection and market readiness, positioning Indian startups for global scalability. Speaking at the event, Dr. M. Srinivas, former Director of AIIMS New Delhi and NITI Aayog member, called the Ayushman Bharat Digital Mission the ‘digital spine’ of India’s healthcare transformation. He stressed that interoperable health infrastructure and data-driven systems would redefine access to care, ensuring equitable outcomes across generations. Shri Bhuvnesh Pratap Singh, Director of Startup India, reinforced the government’s vision of a self-reliant India by 2047, framing accessible healthcare technologies as critical to this goal. Tarun Chaturvedi, COO of FITT IIT Delhi, underscored the need for stronger industry-academia partnerships to translate lab breakthroughs into market solutions. He noted that most innovations fail in the transition from research to real-world application, emphasizing the role of deep-tech startups in overcoming this challenge. Sharad Goswami, Senior Director of Global Policy at Pfizer India, echoed this, stating that sustainable healthcare innovation requires cross-border collaboration and ecosystem support. The event featured discussions on leveraging India’s startup ecosystem to develop globally relevant healthcare solutions. Pfizer’s INDovation program, Goswami said, reflects a long-term commitment to nurturing Indian innovators, positioning the country as a source of transformative healthcare advancements. The gathering united leaders from healthcare, academia, venture capital, and policy to declare India’s growing influence in global health innovation.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.